Melanoma-API Insights, 2015: Market Research, Analysis and Forecast report

Posted by David Lee at 22:34 on Thursday 9 April 2015
ResearchMoz.us include new market research report " Melanoma-API Insights, 2015: Industry Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection of research reports.

Melanoma-API Insights, 2015,report provides Melanoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Melanoma.


The report also highlights the patent, patent exclusivity information and competitive landscape. The research analysis also presents the global sales forecasts data for the Zollinger-Ellison Syndrome (Gastrinoma) drugs till 2016.

The Report provides the India and China API Manufactures who are driving the current API Market. Report also highlights the patent, patent exclusivity information and competitive landscape. The research analysis also presents the global sales forecasts data for the Melanoma drugs till 2016.

The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.

Reasons to Buy:

  • Evaluate the marketing status and exclusivity details of Melanoma key products to exploit opportunities for generic drug development opportunities.
  • Key players in the pharmaceutical industry.
  • Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified.
  • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Melanoma.
  • API intelligence over marketed drugs for Melanoma and gaining primary intelligence over active ingredients manufacturers across the globe.
  • Uncovering opportunities in the rapidly growing the US markets.


India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China.

Browse More reports related to Pharmaceuticals Industry at: http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Scope:

  • A snapshot of the global Market therapeutics scenario for Melanoma.
  • A review of the marketed products under prescription for Melanoma, regulatory information and marketing status.
  • Coverage of global patent coverage and detailed commentaries on the US patent challenges. 
  • Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
  • Product profiles for marketed products for Melanoma with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
  • Coverage of API Manufacturers for Melanoma drugs in the United States, Europe and Asian Regions with location details.
  • Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Melanoma drugs.
  • Key discontinued Marketed products.
  • Global Sales Figure from 2012-2016.


About Us:

ResearchMoz ( http://www.researchmoz.us/ ) is the one stop online destination to find and buy market research reports. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.

For More Information Kindly Contact: 
Mr. Nachiket
Tel:+1-518-618-1030 
Toll Free: 866-997-4948
Labels: , ,

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)